Selected discoveries from human research in space that are relevant to human health on Earth. by Shelhamer, Mark et al.
UC San Diego
UC San Diego Previously Published Works
Title



















eScholarship.org Powered by the California Digital Library
University of California
PERSPECTIVE OPEN
Selected discoveries from human research in space that are
relevant to human health on Earth
Mark Shelhamer1*, Jacob Bloomberg2, Adrian LeBlanc3, G. Kim Prisk4, Jean Sibonga2, Scott M. Smith2, Sara R. Zwart5 and Peter Norsk3
A substantial amount of life-sciences research has been performed in space since the beginning of human spaceflight.
Investigations into bone loss, for example, are well known; other areas, such as neurovestibular function, were expected to be
problematic even before humans ventured into space. Much of this research has been applied research, with a primary goal of
maintaining the health and performance of astronauts in space, as opposed to research to obtain fundamental understanding or to
translate to medical care on Earth. Some people—scientists and concerned citizens—have questioned the broader scientific value
of this research, with the claim that the only reason to perform human research in space is to keep humans healthy in space. Here,
we present examples that demonstrate that, although this research was focused on applied goals for spaceflight participants, the
results of these studies are of fundamental scientific and biomedical importance. We will focus on results from bone physiology,
cardiovascular and pulmonary systems, and neurovestibular studies. In these cases, findings from spaceflight research have
provided a foundation for enhancing healthcare terrestrially and have increased our knowledge of basic physiological processes.
npj Microgravity             (2020) 6:5 ; https://doi.org/10.1038/s41526-020-0095-y
INTRODUCTION
For as long as humans have ventured into space, research has
been performed to study the physiological effects of spaceflight.
The claim is sometimes made that the only reason to do this
research on humans in space is to provide the information that is
needed to keep them alive and well when they are in space—the
implication being that there is little or no fundamental scientific
return from such research.1 Here, we provide evidence to the
contrary. In the course of applied research that is primarily focused
on maintaining astronaut health in space, discoveries have been
made that have a broader impact on fundamental scientific
understanding. That these findings arose in the course of applied
research suggests that there will be other interesting and
important scientific discoveries when and if more open-ended
exploratory science can be performed in space. We present here
five areas of physiology that support this contention.
BONE LOSS IN SPACE: COUNTERMEASURES FOR DISUSE
Even in the years prior to human spaceflight, clinical research
suggested that weightlessness would lead to bone loss, although
the details were uncertain.2,3 Ongoing NASA research has
provided a more general understanding of bone loss and
delineation of the detailed effects of disuse on bone, independent
of disease-related bone loss and recovery. The early Skylab flights
and short-duration missions of Gemini and Apollo led to the
development of densitometry techniques that are now used
widely in clinical settings around the world.4,5 This research shed
light on the rapid bone loss caused by disuse conditions.
Spaceflight research found that bone loss could be continuous
for several months in space, and suggested that recovery after
flight would not be rapid, if it occurred at all. Measurements on
the international crews of Mir, Shuttle/Mir, and ISS documented
continuous loss of areal bone mineral density of 1–2% per month,
which varied greatly between individuals, bones, bone
compartments, and skeletal regions within the same indivi-
dual.6–8 These studies also showed the dichotomy between
cortical and trabecular bone loss with disuse. Some recovery of
lost bone does occur very slowly following return to Earth, but
some loss within the trabecular compartment may be perma-
nent.8–10 This information has been important for NASA planning
and also for terrestrial clinicians attempting to rehabilitate patients
after significant periods of disuse. Mechanistically, during disuse,
systemic markers of bone resorption and urinary calcium excretion
are consistently elevated, while bone formation is unchanged,
suggesting that remodeling is elevated and the dynamics are
uncoupled.11 Alterations in remodeling have been well documen-
ted in most bone diseases, and now it is known that spaceflight
and disuse can result in altered remodeling in healthy subjects,
hence the need to prioritize procedures to minimize the effects of
disuse to the greatest extent possible. NASA has investigated
exercise countermeasures, such as bicycle and treadmill ergome-
try and resistive weight training, that appear to be partially
effective.12 In addition to routine exercise, an antiresorptive agent,
alendronate, taken weekly, has proved to be effective in reducing
bone loss, remodeling rate, and urinary calcium excretion.13 These
results had been verified using the ground-based bed-rest model
of weightlessness, without exercise.14
Notwithstanding the obvious benefits of this research for
science and astronaut health, these findings may also be
important for disuse-related bone changes on Earth. For example,
amputation, lower-leg fractures, ligament tears, and other
clinically-required but temporary disuse conditions lead to bone
loss with delayed or incomplete recovery.15,16 The value of an
antiresorptive medication in these surgical situations requires
future validation. The spaceflight studies indicate that an early
pharmacologic intervention at the beginning of a disuse episode
could be effective in preventing bone loss and, thereby, preserve
bone integrity (especially trabecular structure critical to bone
strength).
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BONE LOSS AND NUTRITION: CALCIUM METABOLISM AND
DIETARY PROTEINS
Nutrition is critical for human health, especially during exploration
in remote regions, where food and nutrient intake may be
compromised. Spaceflight provides a highly controlled environ-
ment with healthy individuals and a high degree of monitoring.
Therefore, it is an ideal experimental setting in which to analyze
the association of nutrients with rapid bone loss and to test the
effects of specific nutrient supplementation. This has led to a
better understanding of the effects of dietary components on
bone,17 and of the effectiveness of vitamin D supplementation in
individuals without natural ultraviolet light exposure.18
Iron stores (reflected by serum ferritin) increase in the early
weeks of spaceflight, then slowly return toward pre-flight levels.19
The increase is associated with evidence of oxidative damage and
bone resorption. Greater extent or duration of ferritin increase
during spaceflight results in a greater decrease in bone mineral
density (hip, trochanter, hip neck, pelvis) after long-duration
flight.20 Also, the ferritin increase has been shown to correlate
with elevated biochemical markers of bone resorption and urinary
calcium excretion during spaceflight. Several human and animal
studies support these findings and show that mild iron excess (but
still within a normal clinical range) is associated with bone loss by
a mechanism believed to be related to oxidative stress.19,21 The
relationships between iron and bone loss during flight were
observed in 4–6-month missions; these same relationships in a
terrestrial study were observed after 3 years,21 likely due to the
fact that bone loss during spaceflight is approximately ten times
faster than on Earth. These findings help identify relationships
between nutrition, oxidative stress, and bone loss and also have
implications for terrestrial health and medicine.
Other dietary factors can influence acid/base balance in the
body, which in turn can affect the skeleton, a source of base
(calcium carbonate) that can neutralize acid loads. Dietary proteins
can contribute to acid load through the production of low levels of
sulfuric acid. Therefore, a high dietary ratio of animal protein (rich
in amino acids) to potassium (typically as base-producing, acid-
neutralizing salts) is associated with increased bone breakdown.20
Furthermore, supplementing a nominal diet with amino acids
during extended bed rest (an analog of spaceflight) leads to
increased acid load and increased bone resorption.22 Recent
spaceflight research has identified that the acid:base potential of
the diet is negatively correlated with bone loss (more acidogenic,
more bone loss).17
The effect of diet on bone loss remains controversial—some
studies have shown protective effects of a high protein diet, but
some studies found a high protein diet could be detrimental.
These discrepancies are likely due to other contributing factors,
such as calcium intake.23–25 As with almost any human research,
controlling for all relevant variables and confounding factors is
challenging. For example, postmenopausal women often suffer
from decreased bone density, but these individuals have varying
diets, levels of physical activity, comorbidities and genetic
influences. Further, it can take years to observe any therapeutic
or detrimental effects of diet since bone loss is much slower than
in space. Astronaut populations are relatively homogenous and
free of comorbidities yet experience accelerated bone resorption
and consume foods from the same controlled and limited food
system, with a shared key environmental stressor: microgravity.
Therefore, the space environment holds the potential to provide
insights into the therapeutic or detrimental effects of nutrients on
bone loss that can be applied to clinical research.
CARDIOVASCULAR SYSTEM: LESSONS LEARNED ABOUT
CENTRAL VENOUS PRESSURE AND LEFT VENTRICULAR END-
DIASTOLIC VOLUME
Blood and other fluids shift from the lower extremities to the
upper body during spaceflight due to the absence of a hydrostatic
gradient in weightlessness.26 It has been speculated that the
repositioning of fluids would increase cardiac preload and central
venous pressure (CVP), with implications for cardiac function.
(Preload, or end-diastolic volume, is the amount of blood in the
ventricles at the end of cardiac filling, before the systolic “pulse”
that sends blood to the peripheral circulation. Higher preload
increases the volume of blood flow in the subsequent contrac-
tion.) CVP in space was first measured with catheters in arm
(cubital) veins and was unexpectedly decreased in flight.27–29 In
another study, CVP was more directly measured with central fluid-
filled catheters during the initial hours of two Space Shuttle
missions. These and other measurements confirmed an in-flight
reduction in CVP and also found an increase in left ventricular
end-diastolic volume (LVEDV, the amount of blood in the ventricle
at the end of filling, just before the systolic pulse).30,31 It was
surprising to find decreased CVP yet increased LVEDV because it is
venous pressure (CVP) that provides the force to fill the ventricles
(LVEDV). Decreased CVP reflects a decrease in cardiac preload and,
thus, should result in a decrease in subsequent atrial volume
and LVEDV.
The ostensible contradiction of a decrease in CVP and an
increase in LVEDV30 was later explained by data from the
weightless phase of parabolic flight, where a decrease in CVP of
1.3 mm Hg was observed.32 At the same time, esophageal
pressure, which reflects intrathoracic pressure (inside the chest
cavity, surrounding the heart), fell by 5.6 mm Hg. The fact that
esophageal pressure fell more than CVP provided the key to
understanding the simultaneous decrease in CVP and increase in
LVEDV in weightlessness. While supine in 1 g, the thorax is
mechanically compressed, which increases CVP relative to
ambient pressure. The importance and magnitude of mechanical
compression pressure for understanding preload changes to the
heart was not known before CVP was measured in
weightlessness.32
The relationship between the expansion of the thorax and
stroke volume and cardiac output observed during spaceflight has
contributed to an understanding of the effects of posture on
heart-lung interactions. The weightlessness-induced change in
CVP relative to intrathoracic pressure (transmural CVP) during
spaceflight leads to increases in stroke volume and cardiac output
of 35% and 41%, respectively, compared to seated upright in
1 g,33 in accordance with the well-known Starling effect34 which
states that stroke volume increases in response to increases in
blood volume in the ventricles prior to contraction. Understanding
that expansion of the thorax helps to increase stroke volume and
cardiac output contributes to basic knowledge of the influence of
gravity and posture on heart-lung interactions. As an example,
measuring CVP as an indication of the change in cardiac preload
during a change in posture (from supine to head-up or vice versa)
can lead to erroneous interpretations of the measurements, if
intrathoracic pressure is not taken into account. The front-to-back
compression of the thorax while supine increases intrathoracic
pressure, which leads to increased LVEDV despite decreased CVP.
The same is likely also true when shifting from supine to
horizontal lateral positions because of a different distribution of
gravitational loading on the thorax.
The findings from space and parabolic flights are also relevant
for understanding how intrathoracic pressure regulation can aid in
the treatment of hypotension and in decreasing intracranial
pressure. Use of an inspiratory threshold device (ITD), which
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increases resistance to inspiration, can increase cardiac filling via
negative-pressure-induced expansion of the thorax during inspira-
tion, resulting in the suction of more blood into the right atrium
and ventricle.35 The ITD can also decrease intracranial pressure in
patients with intracranial hypertension by increasing venous
return and decreasing cerebrospinal fluid pressure through the
inspiratory expansion of the thorax. These medical advances
would not have been possible without the measurements from
spaceflight, parabolic flight, and bed-rest research.
PULMONARY FUNCTION: GRAVITY-INDUCED LUNG
DEFORMATION
Gas exchange in the lung is accomplished by passive diffusion, in
which inspired gas and circulating blood must be brought
together in appropriate proportions across a very thin (alveolar)
membrane. In the 1950s, after the advent of radiolabeled tracers,
the effects of gravity on the perfusion of the lung were first
appreciated. The first few studies found that ventilation varied
according to gravity level and, together with very low pulmonary
vascular perfusion pressures, affected gas exchange, with a
gravity-induced reduction in exchange efficiency as a direct
consequence of ventilation-perfusion mismatch.36–39 These obser-
vations help to explain much of the age-related impairment in
pulmonary gas exchange as the aging lung in geriatric patients
deforms more under the influence of gravity.
The expectation then was that in weightlessness ventilation,
perfusion, and the matching of ventilation to perfusion would
become uniform (lacking in gradients due to gravity).40 Observa-
tions showed that while ventilation (the air that reaches the
alveoli)41 and perfusion (the blood that reaches the alveoli)42 were
indeed much more uniform, some residual inhomogeneity
remained, likely due to the complicated structure of the lung.
The observations showed, more importantly, that the matching of
ventilation to perfusion was no better than that seen on the
ground.43 This initially paradoxical observation, which could not
be readily appreciated in terrestrial experiments, is now known to
be a direct consequence of the coupling of ventilation and
perfusion. Gravity deforms the lung, resulting in uneven ventila-
tion,44 and similarly causes uneven perfusion.45 Thus, in the
normal human lung, gravity serves effectively to maintain the
matching of ventilation to perfusion through mechanical effects46
and thus to maintain efficient gas exchange. However, as lung
weight is increased – as is often the case in intensive-care
situations with excess fluid accumulation – lung deformation
increases, regions of the lung become unventilated, and gas
exchange becomes compromised. Understanding the nature of
lung deformation and how gravity affects gas exchange – an
understanding improved through spaceflight studies— is a matter
of critical importance in the intensive care unit where prone
positioning in some patients results in significant reductions in
mortality.47
SENSORIMOTOR AND NEUROVESTIBULAR FUNCTION:
PERCEPTION AND ORIENTATION IN ALTERED GRAVITY
Among the most widespread biomedical impacts from spaceflight
may be those in the area of neurovestibular function, given its
long history going back to high-performance aircraft flight,
predating spaceflight.48 Research in this area has contributed to
basic understanding of the remarkable capacity for adaptive
plasticity. Humans have a lifetime of experience and neural
development (and many years of evolution) in a constant gravity
field. The combination of sensory information that results from
movement in this gravity field takes gravity into account. Consider
a head tilt: the vestibular semicircular canals sense angular
velocity, the vestibular otolith organs detect a change in
orientation with respect to gravity, and proprioceptors are
triggered by neck flexion. In a weightless environment, the otolith
tilt signal is missing, but despite a lifetime of experience with
normal Earth gravity, astronauts adjust to this “missing” otolith
signal within a matter of days.49 Aspects of this neuroplasticity
have informed training programs to improve motor function in
clinical populations. An example is a better understanding of the
role of gravity loading in maintaining muscle and motor function,
and the importance of maintaining loading to prevent degen-
erative changes in protein metabolism and muscle fibers that can
impair rehabilitation after spinal-cord injury.50
Another unexpected observation was the ability to evoke
caloric nystagmus in orbital flight.51 Nystagmus is the repetitive
reflexive motion made by the eyes to maintain gaze stability when
the head is rotated. It can also be stimulated, as a test of vestibular
function, by irrigating the ear with hot or cold water, which sets up
convection within the fluid of the semicircular canals. Since fluid in
the canals under normal circumstances is only set in motion when
the head moves, caloric stimulation mimics an extended head
rotation and induces the corresponding nystagmus. The presence
of caloric nystagmus in space was surprising because the
dominant stimulus on Earth is convection in the fluid in the inner
ear. With the weightlessness of space, there is no convection and
therefore, there should be no caloric nystagmus. Later studies
investigated this phenomenon and determined that there is a
direct thermal effect of caloric stimulation on the semicircular
canals of the vestibular system,52 which slightly expands the canal
membrane and induces fluid motion within the canal. This
furthered the understanding of this very commonly used
diagnostic tool.
Another neurovestibular discovery that was uncovered during
spaceflight research was the role of otolith asymmetry on ocular
alignment and space motion sickness.53 The otolith organs in each
vestibular labyrinth contain small crystals of calcium carbonate
(otoconia); the relative motions of the otoconia detect linear
accelerations and gravity. There is reason to believe that the body
does not maintain perfect symmetry (equal masses) of the
otoconia between the two inner ears, leading to slightly different
sensitivities in vestibular sensing across the midline.54 The
weightlessness of spaceflight made it clear that there is a central
compensation mechanism for this tonic imbalance that is normally
appropriate for an Earth-gravity environment; changes in ocular
alignment (mediated by the otolith organs) and susceptibility to
space motion sickness have been correlated with this asymmetry,
which can be measured with simple assessment of the alignment
of the two eyes in different gravity levels.53 Recognition of the role
of such otolith asymmetry in vestibular-mediated responses has
led to research that examines changes in one such response –
vertical and torsional alignments of the eyes – under peripheral or
central insult. Assessment of this response is aiding the under-
standing of traumatic injuries due to blast in military
populations.55
CONCLUSION
The challenges of performing physiological research in space
should not be underestimated. This type of research is subject to
many confounds: significant operational constraints, limited
experimental controls, limited opportunities for repetition and
validation, and small numbers of subjects. Despite these
complications, NASA and its international partners have carried
out a successful research program that has produced many
important results. These results not only provide practical
information to maintain astronaut health and safety in space,56
they also provide important information for fundamental scientific
understanding. These scientific results also help us catalog the
range of possible adaptive processes that might have aided in our
development and adjustment to Earth, and suggest limits on the
ability to live in extreme settings. All of these provide a broader
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perspective not just on physiology and human health, but on our
place in the universe.
Reporting summary
Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
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